OraSure Technologies, Inc. Logo
OraSure Reports Q1 ’24 Revenue of $54.1 Million
May 08, 2024 16:05 ET | OraSure Technologies, Inc.
Q1 GAAP EPS of $(0.05); Q1 Non-GAAP EPS of $0.04 Restructuring initiatives expected to result in $15 million of annualized expense reductions once fully implemented and position OraSure to achieve...
Magnite Reports First Quarter 2024 Results
May 08, 2024 16:05 ET | Magnite, Inc.
Magnite Reports First Quarter 2024 Results
newfhrlogo.jpg
Full House Resorts Announces First Quarter Results
May 08, 2024 16:05 ET | Full House Resorts, Inc.
- Revenues Increased 39.6% to $69.9 Million in the First Quarter of 2024 - American Place Casino Celebrates Its First Anniversary With Strong Performance Gains - Chamonix Casino Hotel Continued...
AssemblyBio_logo_RGB.png
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
May 08, 2024 16:05 ET | Assembly Biosciences, Inc.
Clinical trial application clearances received for a Phase 1a/1b trial for ABI-5366 targeting recurrent genital herpes, and a Phase 1b trial for ABI-4334 in chronic HBV infection; both studies on...
RM Primary Logo - Humble.png
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
May 08, 2024 16:02 ET | Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Olema_Oncology_HIGH RES LOGO.png
Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 08, 2024 16:02 ET | Olema Oncology
Completed enrollment in 60-patient Phase 1b/2 clinical studies of palazestrant in combination with each of ribociclib and palbociclibNew clinical data from palazestrant-ribociclib combination study to...
Sunrun_logo_darkblue.jpg
Sunrun Reports First Quarter 2024 Financial Results
May 08, 2024 16:01 ET | Sunrun Inc.
Sunrun Reports First Quarter 2024 Financial Results
duolingo logo.png
Duolingo Reports 45% Revenue Growth and Record Profitability in First Quarter 2024; Raises Full Year Guidance
May 08, 2024 16:01 ET | Duolingo, Inc.
PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL), the world’s leading mobile learning platform, announced results for the first quarter ended March 31, 2024 in a...
Cytokinetics.png
Cytokinetics Reports First Quarter 2024 Financial Results
May 08, 2024 16:00 ET | Cytokinetics, Incorporated
Primary Results and Two Additional Analyses from SEQUOIA-HCM to be Presented in a Late-Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress Opened...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
May 08, 2024 09:15 ET | Cyclacel
BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...